EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Tumor-Infiltrating Lymphocyte (TIL) as a Prognostic Factor and for Treating Invasive Cutaneous Melanoma

Gabriel Alves Freiria de Oliveira, Daniel Arcuschin de Oliveira iD, Melissa Yoshimi Sakamoto Maeda Nisimoto, Rafael Rubinho, Heitor Carvalho Gomes, Luciana Cavalheiro Marti iD, Renato Santos de Oliveira Filho iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252312596 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Gabriel Alves Freiria de Oliveira und 6 weiteren Autor:innen. Beteiligte Einrichtung: Melanoma and Skin Tumors Sector, Plastic Surgery Discipline, Escola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP), Rua Botucat…. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Cutaneous Malignant Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Invasive cutaneous melanoma is responsible for about 5% of skin tumors yet is liable for nearly 70% of skin cancer-related deaths. Despite notable advancements over the past decade, including immunotherapies and targeted treatments, more than half of invasive melanoma patients ultimately succumb to the disease due to therapeutic resistance. To overcome this obstacle, strategies such as combining immunotherapies with targeted drugs or adding epigenetic therapies have been investigated. Tumor-infiltrating lymphocytes (TILs) therapy has emerged as a promising option for patients whose disease continues to progress despite standard treatments. This article aims to introduce TIL therapy and review recent outcomes in melanoma prognosis in its application for melanoma management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocytes, Tumor-InfiltratingCutaneous Malignant MelanomaSkin NeoplasmsHumansImmunotherapyMelanomaNeoplasm InvasivenessPrognosis

Stichwörter der Autor:innen

cutaneous melanomamelanomametastatic melanomatumor-infiltrating lymphocytes (TILs)

Autor:innen und Institutionen

  • Melanoma and Skin Tumors Sector, Plastic Surgery Discipline, Escola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP), Rua Botucatu, 740, São Paulo 04023-062, SP, Brazil.
  • Department of Dermatology, Universidade Santo Amaro, Rua Isabel Schmidt, 349, Santo Amaro, São Paulo 04743-030, SP, Brazil.
  • Department of Experimental Research, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, Morumbi, São Paulo 05653-000, SP, Brazil.

ORCID-Profile: Daniel Arcuschin de Oliveira, Luciana Cavalheiro Marti, Renato Santos de Oliveira Filho

Zitieren

APA

de Oliveira, G. A. F., de Oliveira, D. A., Nisimoto, M. Y. S. M., Rubinho, R., Gomes, H. C., Marti, L. C., & de Oliveira Filho, R. S. (2024). Advances in Tumor-Infiltrating Lymphocyte (TIL) as a Prognostic Factor and for Treating Invasive Cutaneous Melanoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312596

Vancouver

de Oliveira GAF, de Oliveira DA, Nisimoto MYSM, Rubinho R, Gomes HC, Marti LC, et al. Advances in Tumor-Infiltrating Lymphocyte (TIL) as a Prognostic Factor and for Treating Invasive Cutaneous Melanoma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312596

BibTeX
@article{deOliveira2024,
  author = {de Oliveira, Gabriel Alves Freiria and de Oliveira, Daniel Arcuschin and Nisimoto, Melissa Yoshimi Sakamoto Maeda and Rubinho, Rafael and Gomes, Heitor Carvalho and Marti, Luciana Cavalheiro and de Oliveira Filho, Renato Santos},
  title = {Advances in Tumor-Infiltrating Lymphocyte (TIL) as a Prognostic Factor and for Treating Invasive Cutaneous Melanoma},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252312596}
}
Kostenlos starten →